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A	 versatile	 method	 for	 the	 selective	 core-crosslinking	 of	 hyaluronic	 acid-
based	 nanogels	 via	 ketone-hydrazide	 chemistry:	 from	 chemical	
characterization	to	in	vivo	biodistribution	Francielle	Pelegrin	Garcia	a,b,	Marlene	Rippe	a,	Mychelle	Vianna	b,	Talitha	Fernandes	Stefanello	a,b,	Benoit	Louagec,	Simon	Van	Herckc,	Lucie	Sanceyd,	Jean-Luc	Colld,	Bruno	G.	De	Geestc,	Celso	Vataru	Nakamura	b,	Rachel	Auzély-Velty*a		The	development	 of	 biopolymer-based	nanogels	 has	 gained	particular	 interest	 to	 achieve	 successful	 delivery	 of	 therapeutics	 for	 the	 treatment	 of	various	 diseases,	 such	 as	 cancer,	 infection	 and	 diabetes.	 Herein,	 we	 report	 a	 new	 and	 simple	methodology	 for	 the	 covalent	 stabilization	 of	 self-assembled	 gel	 nanoparticles	 based	 on	 hyaluronic	 acid	 (HA)	 modified	 with	 a	 thermoresponsive	 ketone-functional	 copolymer.	 This	 relies	 on	 the	selective	formation	of	hydrazone	crosslinks	with	bishydrazides	within	the	globular	domains	of	the	copolymer	chains	formed	above	the	cloud	point	temperature.	 This	 approach	 allows	 tuning	 the	 crosslinking	 density	 by	 varying	 the	 dihydrazide	 crosslinker	 to	 ketone	 molar	 ratio.	 The	 size	distributions	 and	 morphology	 of	 the	 nanogels	 were	 assessed	 using	 dynamic	 light	 scattering	 (DLS),	 cryo-transmission	 and	 scannning	 electron	microscopy.	 In	vitro	 cellular	uptake	 in	several	 cancer	cells	and	 in	vivo	biodistribution	of	 the	nanogels	 in	different	mouse	 tumor	models	were	 then	explored	to	assess	the	effectiveness	of	this	crosslinking	strategy.	The	data	from	these	experiments	show	prolonged	blood	circulation,	longer	than	24	hours,	for	the	crosslinked	nanogels	and	high	tumor	accumulation.	
Introduction		1	Self-assembled	 gel	 nanoparticles	 (also	 called	 nanogels)	 made	 of	 hydrophobically	 modified	 biopolymers	 have	 attracted	 growing	2	interest	for	drug	delivery	to	tumors	as	these	systems	combine	the	advantages	of	hydrogels	with	nanoscale	formulations.1-5	Their	size	3	can	be	easily	tuned	from	tens	to	several	hundreds	of	nanometer,	their	inner	network	comprising	hydrophobic	domains	can	be	used	4	to	incorporate	poorly	water-soluble	drugs	and	their	hydrophilic	shell	can	be	exploited	to	control	their	biological	fate	and	targeting	5	ability.	However,	one	practical	challenge	with	such	carrier	systems	is	their	tendency	to	disassemble	in	the	bloodstream	because	of	6	the	large	dilution	volume	and/or	interactions	with	serum	proteins.6	These	negative	events	reduce	the	efficiency	of	tumor-targeted	7	drug	delivery	via	the	enhanced	permeability	and	retention	(EPR)	effect7,	8.	To	stabilize	the	nanocarriers,	strategies	of	shell	or	core-8	crosslinking	have	been	employed.9-13	Among	these	methods,	crosslinking	the	hydrophobic	domains	in	the	nanogel	core	rather	than	9	the	hydrophilic	shell	has	the	advantage	of	preserving	the	intrinsic	properties	of	the	biopolymer	forming	the	hydrophilic	shell.		10	 In	 this	 study,	 we	 aimed	 to	 establish	 a	 simple	 and	 reliable	 method	 for	 the	 synthesis	 of	 core-crosslinked	 nanogels	 based	 on	11	hyaluronic	 acid	 (HA)	 for	 improved	 nanogel	 stability	 in	 view	 of	 in	 vivo	 tumor-targeting.	 HA,	 a	 polysaccharide	 which	 is	 a	 main	12	component	 of	 the	 extracellular	matrix,	was	 selected	 as	 hydrophilic	 component	 due	 its	 biocompatibility,	 biodegradability	 and	 the	13	existence	of	various	functional	groups	that	are	accessible	for	chemical	modification.14	Despite	intensive	research	on	self-assembled	14	nanoparticles	based	on	hydrophobically	modified	HA	for	targeted	anti-cancer	drug	delivery,14-16	core-crosslinking	has	only	recently	15	been	 explored	 to	 address	 the	 issue	 of	 nanoparticle	 stability	 under	 diluted	 serum-rich	 conditions.	 In	 reported	 examples,	 the	16	hydrophobic	core	of	HA-based	nanoparticles	was	crosslinked	by	disulfide-	or	photo-mediated	crosslinking.	Here,	we	present	a	new	17	approach	based	on	acylhydrazone	chemistry	allowing to	 tailor	 the	density	of	crosslinking.17-21	Key	to	our	strategy	 is	 the	chemical	18	modification	 of	 HA	 by	 a	 temperature-responsive	 keto-functional	 polymer	 which	 can	 be	 efficiently	 crosslinked	 by	 bifunctional	19	hydrazides	in	aqueous	medium	(Scheme	1).	Keto-functionalized	polymers	have	been	demonstrated	to	be	useful	reactive	scaffolds	for	20	the	design	of	complex	macromolecular	architectures	and	for	the	conjugation	of	fragile	biomolecules	since	they	can	be	modified	easily	21	and	in	high	yield.22-27	Herein,	the	keto-polymer	plays	a	dual	role:	i)	in	inducing	hydrophobically-driven	self-assembly	of	modified	HA	22	into	nanogels	due	 to	 its	dehydration	upon	heating,	 and	 ii)	 in	 stabilizing	 the	nanogel	 structure	 through	crosslinking	by	hydrazone	23	bond	formation	between	ketones	and	hydrazides.	We	further	investigated	cellular	uptake	of	the	nanogels	in	several	cancer	cells	and	24	their	in	vivo	biodistribution	to	assess	their	tumor	targeting	potential.	25		26	
Materials	and	methods	27	
Materials		28	
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Hyaluronic	 acid	 (Mw	 =	 40	 kg/mol)	 was	 purchased	 from	 Lifecore	 (USA).	 Diacetone	 acrylamide	 (DAAM),	N,N-dimethylacrylamide	1	(DMA),	 2,2-azobis(2-methylpropionitrile)	 (AIBN),	 phosphate	 buffer	 saline	 (PBS,	 pH	 7.4),	 Tris-(2-carboxyethyl)	 phosphine	2	hydrochloride	(TCEP),	mercaptopropionic	acid	(MPA),	3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium	bromide	(MTT)	and	4-3	(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium	 chloride	 (DMTMM),	 isophtalic	 acid	 dihydrazide	 (IDH),	 hyaluronidase	4	(type	 IV	 from	 bovine	 testes)	 were	 purchased	 from	 Sigma-Aldrich-Fluka	 (France).	 Aminoethylmaleimide	 hydrochloride	 was	5	purchased	 from	 Aokchem.	 N-hydroxysulfosuccinimide	 sodium	 salt	 (sulfo-NHS)	 was	 obtained	 from	 Chemrio.	 N-(3-6	dimethylaminopropyl)-N’-ethylcarbodiimide	 hydrochloride	 (EDC)	was	 purchased	 from	Acros	Organics.	 Dulbecco’s	Modified	 Eagle	7	Medium	 (DMEM),	 L-glutamine,	 sodium	 pyruvate,	 fetal	 bovine	 serum	 (FBS),	 penicillin	 and	 streptomycin	were	 provided	 by	 Gibco.	8	Cyanine	5.5-amine	 (Cy5.5-amine)	was	 purchased	 from	Lumiprobe.	 All	 chemicals	were	 used	without	 any	 further	 purification.	 The	9	positively	 charged	 resin,	 diethylaminoethyl	 cellulose	 (DEAE)	 was	 purchased	 from	 GE	 Healthcare	 Life	 Science.	 2-10	(Butylthiocarbonothioylthio)propanoic	acid	(PABTC)	was	synthesized	as	previously	reported.28	The	water	used	 in	all	experiments	11	was	purified	by	an	Elga	Purelab	purification	system,	with	a	resistivity	of	18.2	MΩ	cm.		12		13	
Analytical	techniques		14	1H	NMR	spectra	were	recorded	at	25	°C	using	a	Bruker	AVANCE	III	HD	spectrometer	operating	at	400	MHz.	Deuterium	oxide	(D2O)	15	and	dimethysulfoxide-d6	(DMSO-d6)	were	obtained	from	SDS	(Vitry,	France).	All	spectra	were	recorded	by	applying	a	45°	tip	angle	16	for	the	excitation	pulse,	and	a	10	s	recycle	delay.	Chemical	shifts	(δ	in	ppm)	are	given	relative	to	external	tetramethylsilane	(TMS	=	0	17	ppm)	and	calibration	was	performed	using	the	signal	of	the	residual	protons	of	the	solvent	as	a	secondary	reference.	The	number-18	average	molar	mass	(Mn),	the	weight-average	molar	mass	(Mw)	and	the	dispersity	(Đ)	of	poly(DAAM-co-DMA)	were	determined	by	19	size	exclusion	chromatography	(SEC)	in	dimethylformamide	containing	50	mM	NaNO3.	Measurements	were	done	on	a	GPC	system	20	equipped	with	a	Waters	model	515	pump,	a	 refractive	 Index	Detector	RI	2000	 from	Schambeck	SFD	GmbH	and	a	 light	 scattering	21	detector	(MALLS)	from	Wyatt	(USA);	Samples	were	recorded	at	30	°C	and	at	a	flow	rate	of	1	mL/min.	The	cloud	point	temperature	22	(Tcp)	of	poly(DAAM-co-DMA)	was	determined	by	UV-vis	turbidity	measurements	(λ	=	500	nm)	performed	on	a	Varian	Cary	50	Scan.	23	The	samples	were	prepared	at	room	temperature	 in	PBS	(1	and	3	g/L),	after	which	the	sample	was	placed	in	the	 instrument.	The	24	light	transmittance	was	measured	during	at	least	two	controlled	cooling/heating	cycles	from	15	°C	to	35	°C	using	a	2	°C	interval.	TCP	25	was	considered	to	be	the	temperature	at	which	the	light	transmittance	was	50	%	of	that	obtained	for	the	same	sample	at	15	°C.	The	26	critical	 aggregation	 temperature	 (CAT)	 of	 HA-m-poly(DAAM-co-DMA)	 in	 aqueous	 solution	was	 assessed	 by	 static	 light	 scattering	27	(SLS)	using	 an	 ALV	 5000	 device	 (ALV-Langen,	 Germany)	 equipped	with	 a	 red	 helium-neon	 laser	 at	 a	wavelength	 of	 632.8	nm.	A	28	solution	of	HA-m-poly(DAAM-co-DMA)	in	PBS	at	a	concentration	of	0.5	g/L	was	filtered	through	a	1.2	µm	polycarbonate	filter	and	29	heated	from	10	to	50	°C	using	a	5	°C	interval.	The	light	scattering	intensity	(LSI)	was	measured	at	90°	angle	for	60	s.	The	CAT,	defined	30	as	the	temperature	at	the	inflection	point	of	the	plotted	curve,	was	found	to	be	32	°C.	The	size	and	size	distribution	of	nanogels	were	31	
Scheme	1.	Formation	of	hyaluronic	acid-based	nanogels	by	temperature-induced	self-assembly	and	their	covalent	crosslinking	by	hydrazone	bond	formation	within	the	hydrophobic	domains	of	the	grafted	copolymer	chains.	
 
		 Biomater.	Sci. , 	2018,	00 , 	1-3	|	3 	
measured	by	dynamic	light	scattering	(DLS)	using	a	Zetasizer	NanoZS	Malvern	Instruments	apparatus	operating	with	a	HeNe	laser	at	1	173°.	The	hydrodynamic	diameters	were	calculated	from	diffusion	coefficients	using	the	Stokes-Einstein	equation.	All	correlogram	2	analyses	were	performed	with	software	supplied	by	the	manufacturer.	All	the	measurements	were	performed	in	PBS	(pH	7.4,	[NaCl]	3	=	0.15	M).	4	
Synthesis	of	copolymer	poly(DAAM-co-DMA)		5	DMA	(0.515	mL,	5	mmol)	and	DAAM	(1.69	g,	10	mmol),	the	RAFT	agent	PABTC	(35.7	mg,	0.2	mmol)	and	AIBN	(5	mg,	0.03	mmol)	in	7	6	mL	anhydrous	dioxane	were	placed	into	a	Schlenk	tube	under	nitrogen.	After	5	freeze-pump-thaw	cycles	for	the	deoxygenation	of	7	the	 solution,	 the	 resulting	 solution	was	 immersed	 in	 a	 thermostated	 oil	 bath	 at	 75	 °C	 and	 left	 to	 react	 for	 3	 h.	 The	 reaction	was	8	quenched	by	cooling	and	exposure	to	oxygen.	The	resulting	polymer	was	precipitated	in	cold	hexane.	The	precipitate	was	dissolved	9	in	acetone	and	the	copolymer	was	precipitated	again	in	hexane.	This	step	was	repeated	3	times	to	give	1.85	g	of	pure	poly(DAAM57-10	co-DMA33).	Samples	taken	before	and	during	the	polymerization	were	analyzed	by	1H	NMR	to	determine	monomers	conversion.	The	11	Mn,	Mw	and	Đ	values	of	the	copolymer	were	determined	by	SEC	in	DMF.	12	
Synthesis	of	HA-m-poly(DAAM-co-DMA)		13	Prior	 to	 the	 coupling	 reaction	 with	 HA-maleimide,	 the	 poly(DAAM-co-DMA)	 copolymer	 was	 subjected	 to	 aminolysis	 using	 n-14	butylamine,	 to	 convert	 the	 RAFT	 end-group	 to	 a	 thiol.	 Briefly,	 the	 copolymer	 (0.370	 g,	 0.225	 mmol)	 was	 solubilized	 in	15	tetrahydrofuran	 (10	 mL)	 and	 n-butylamine	 (4	 mL,	 0.04	 mol)	 was	 added.	 After	 5	 min	 under	 stirring,	 the	 reaction	 mixture	 was	16	concentrated	 under	 reduced	 pressure,	 resulting	 in	 a	 waxy	 liquid	 that	 was	 solubilized	 in	 THF.	 The	 copolymer	 was	 recovered	 by	17	precipitation	in	cyclohexane	and	dried	under	vacuum	at	45	°C	to	obtain	a	white	powder.	Next,	the	thiol-capped	copolymer	(0.360	g,	18	0.0218	mmol)	was	solubilized	in	10	mL	of	water/ethanol	(3:2,	v/v)	and	TCEP	(0.0063	g,	0.0218	mmol)	was	added.	After	30	min	of	19	stirring	at	4	°C	under	nitrogen	atmosphere,	the	copolymer	solution	was	added	to	a	solution	of	HA-maleimide	(0.124	mmol)	in	40	mL	20	of	PBS/ethanol	(3:2,	v/v),	to	perform	the	coupling	reaction	via	Michael	addition,	as	previously	described29.	21	 To	 prepare	 the	 HA-maleimide	 derivative,	 HA	 (0.065	 g,	 0.162	 mmol)	 was	 dissolved	 in	 31.5	 mL	 of	 a	 water/ethanol	 mixture	22	(2:1,v/v)	and	sodium	chloride	(0.257	g,	7.24	mmol)	was	added.	Next,	aminoethylmaleimide	hydrochloride	(0.068	g,	0.385	mmol),	23	sulfo-NHS	(0.070	g,	0.324	mmol)	and	EDC	(0.124	g,	0.65	mmol)	were	added	and	the	pH	of	the	solution	was	maintained	between	4.5	24	and	5	until	no	 further	 change	of	pH	was	observed	 (≈	4	h).	The	 resulting	product	was	purified	by	diafiltration	using	a	membrane	25	Amicon	Ultracel	MWCO	10	KDa	and	recovered	in	pure	water	(24	mL).	Then,	PBS	0.1	M	(10-fold	concentrated)	(2.4	mL)	was	added,	26	followed	by	immediately	adjusting	the	pH	to	4.5.	Finally,	the	copolymer	solution	was	added	to	the	HA-maleimide	solution	(0.050	g	in	27	18.5	mL,	0.124	mmol)	and	the	reaction	mixture	was	stirred	at	4	°C	for	4	h.	The	remaining	maleimide	units	were	then	converted	to	28	carboxylic	 acid	 derivatives	 by	 addition	 of	 excess	 MPA	 (42.5	 µL,	 0.49	mmol).	 After	 stirring	 for	 6	 h,	 the	 HA-poly(DMA-co-DAAM)	29	derivative	was	purified	via	 a	batch	 ion	exchange	process	using	DEAE	Sepharose	CL-6B	as	 a	weak-anion	exchanger.	Briefly,	DEAE	30	resin	(20	mL),	stored	in	a	solution	of	ethanol	30	%,	was	washed	three	times	with	ultrapure	water	at	4	°C	(3	×	20	mL,	contact	times	of	31	10	min).	 Excess	 liquid	was	 removed	by	 centrifugation	 (10,000	 rpm,	10	min)	 at	 4°	C.	 Then,	 the	 resin	was	 activated	by	 successive	32	washes	with	a	0.5	M	NaCl	aqueous	solution	 (20	mL),	 a	1	M	NaCl	aqueous	solution	 (20	mL)	and	 finally,	 four	 times	with	ultrapure	33	water	(4	×	20	mL).	The	HA-poly(DMA-co-DAAM)	derivative	was	then	added	to	the	resin	in	a	conical	tube	and	allowed	to	interact	with	34	the	resin	overnight	at	4°C	under	stirring	with	an	orbital	shaker.	Then,	 the	HA-derivative	bound	to	the	resin	was	subjected	to	 four	35	washes	with	ultrapure	water	(4	×	20	mL)	to	remove	non-grafted	copolymer.	Finally,	the	HA-derivative	was	eluted	with	a	1	M	NaCl	36	aqueous	solution	(4	×	10	mL).	After	filtration	of	the	solutions	of	the	recovered	HA	derivative	through	a	Buchner	funnel	containing	a	37	porous	glass	filter	plate	(porosity	4),	the	solution	was	dialyzed	against	deionized	water	using	a	dialysis	membrane	MWCO	100	kDa	38	for	48	h.	The	product	was	recovered	by	freeze-drying	as	a	white	powder.	39	
Determination	of	the	poly(DAAM-co-DMA)	content	in	HA-m-poly(DAAM-co-DMA)	samples	by	the	carbazole	reaction		40	The	degree	of	substitution	(DS),	defined	as	the	average	number	of	copolymer	units	per	repeating	disaccharide	unit,	was	indirectly	41	determined	by	reaction	of	D-glucuronic	acid	units	of	HA	with	carbazole30.	Briefly,	800	µL	of	25	mM	sodium	tetraborate	solution	in	42	sulfuric	acid	was	added	to	an	aqueous	solution	of	HA-m-poly(DAAM-co-DMA)	(200	µL)	at	a	concentration	of	0.34	g/L.	After	heating	43	at	100	°C	for	10	min,	the	solution	was	cooled	at	room	temperature	for	15	min,	and	then	a	solution	of	carbazole	(200	µL)	in	absolute	44	ethanol	 0.125	%	 (m/v)	 was	 added.	 The	 sample	 was	 heated	 again	 at	 100	 °C	 for	 10	 min	 and	 its	 absorbance	 was	 determined	 by	45	spectrophotometry	at	530	nm.	The	HA	concentration	was	calculated	from	a	calibration	curve	(0.050	to	0.250	g/L),	which	allowed	the	46	indirect	determination	of	the	copolymer	amount	in	the	HA-m-poly(DAAM-co-DMA)	sample.	47	
Nanogel	crosslinking	48	To	a	solution	of	HA-m-poly(DMA-co-DAAM)	(0.005	g,	0.0026	mmol)	with	a	DS	of	0.1	at	a	concentration	of	1	g/L	in	PBS	(pH	7.4)	at	49	room	temperature,	a	solution	of	isophtalic	acid	dihydrazide	(IDH)	in	DMSO	(0.073	g/mL)	was	added	under	stirring.	The	volume	of	50	the	 IDH	 solution	 (20,	 40	 and	 60	 µL)	 was	 varied	 to	 obtain	 IDH/ketone	 molar	 ratios	 of	 0.5,	 1.0	 and	 1.5,	 respectively.	 Next,	 the	51	
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temperature	of	the	solution	was	increased	to	40	°C.	After	stirring	at	40	°C	for	24	h,	the	nanogels	suspension	was	transferred	into	a	1	dialysis	bag	 (MWCO	=	6-8	kDa)	 and	dialyzed	against	deionized	water	 for	48	h.	The	 core	 cross-linked	nanogels	were	 recovered	by	2	freeze-drying.	3	
Labeling	of	crosslinked	nanogels	based	on	HA-m-poly(DAAM-co-DMA)	and	native	HA	with	Cy5.5	4	Fluorescent	nanogels	were	obtained	by	grafting	the	dye	Cy5.5-amine	on	crosslinked	nanogels	based	on	HA-m-poly(DAAM-co-DMA)	5	by	an	amine-acid	coupling	reaction	using	DMTMM	as	a	coupling	agent31.	To	this	end,	crosslinked	nanogels	(0.010	g,	0.0052	mmol)	6	were	 solubilized	 in	 water/DMF	 (1:1	 v/v;	 4	mL)	 and	 DMTMM	 (1.467	mg,	 0.0052	mmol)	 was	 added	 to	 the	 solution,	 followed	 by	7	adjusting	 the	pH	 to	6.5.	After	30	min	of	 stirring,	Cy5.5-amine	 (0.099	mg,	0.00013	mmol)	 solubilized	 in	water/DMF	 (1:1	v/v)	at	 a	8	concentration	of	1	g/L	was	added	to	the	reaction	mixture.	After	stirring	at	room	temperature	for	48	h,	the	nanogels	were	purified	by	9	dialysis	using	a	membrane	MWCO	6-8	KDa	against	deionized	water	for	48	h	and	recovered	by	freeze-drying.	Cy5.5-labeled	HA	was	10	prepared	from	native	HA	and	Cy5.5-amine	according	to	the	same	procedure.	11	
Scanning	electron	microscopy	12	Drops	of	crosslinked	nanogels	solutions	(0.5	g/L)	in	pure	water	at	both	5	and	40	°C	were	deposited	onto	mica-coated	copper	stubs	13	(also	 precooled/heated	 at	 5	 or	 40	 °C,	 respectively)	 and	 allowed	 to	 air-drying	 at	 4	 or	 40	 °C.	 The	 samples	 were	 then	 coated	 by	14	approximately	2	nm	of	sputtered	Au-Pd	and	observed	in	secondary	electron	imaging	mode	with	a	ZEISS	Ultra	55	FEG-SEM	(Grenoble	15	INP	-	CMTC).	Images	were	acquired	at	low	voltage	of	3	kV	using	an	in-lens	detector.	16	
Cryo-transmission	electron	microscopy	17	Cryo-TEM	 samples	were	 prepared	with	 an	 automated	 vitrification	 system	 (Vitrobot	Mark	 IV,	 FEI,	 The	 Netherlands).	 Crosslinked	18	nanogels	solutions	(5	g/L)	was	placed	on	Lacey	carbon	grids	(TedPella	Inc,	California,	USA)	charged	previously	by	glow	discharge	19	with	15	mA	for	10	seconds	in	air	atmosphere	to	make	them	hydrophilic	(Pelco	easiGlow).	Specimens	were	prepared	in	a	controlled	20	environment	with	the	temperature	and	humidity	set	to	22	°C	for	5	°C	sample	and	37	°C	and	100	%	for	humidity,	respectively,	which	21	prevented	sample	evaporation	sample	during	the	preparation.	A	3	µL	sample	droplet	was	deposited	on	a	300	mesh	 lacey	carbon-22	coated	cooper	grid	(Ted	Pella).	The	excess	fluid	was	blotted	off	to	create	an	ultra-thin	layer,	which	spans	the	holes	of	the	support	film	23	of	the	solutions,	and	prepared	with	blot	force	of	approximately	-5,	blot	wait	of	20	seconds	and	blot	time	of	3	seconds	of	waiting	time	24	before	blotting.	The	prepared	samples	were	immediately	vitrified	by	propelling	the	grids	into	liquid	ethane	at	its	freezing	point	(-184	25	°C).	The	vitrified	sample	grids	were	transferred	under	liquid	nitrogen	by	the	use	of	a	Gatan	(Pleasanton,	CA,	USA)	cryo-holder	(Model	26	626)	into	a	JEOL	JEM-1400	plus	TEM	(Jeol,	USA)	equipped	with	FEG	and	operated	at	120	kV	acceleration	voltage.	Microscopy	was	27	carried	out	at	-175	°C	sample	temperature	with	a	defocus	range	of	-2	to	-4	μm.	Images	were	acquired	using	an	F-416	CMOS	camera	28	(TVIPS,	Germany).	Sample	preparation	and	data	acquisition	were	performed	at	the	Electron	Microscopy	Laboratory	(LME)/Brazilian	29	Nanotechnology	National	Laboratory	(LNNano).	30	
Cell	culture	31	Cells	were	obtained	 from	American	Type	Tissue	Culture	 (ATCC,	Maryland),	or	European	Collection	of	Authenticated	Cell	Cultures	32	(ECACC).	Human	cervical	cancer	cells	(HeLa	cells)	were	cultured	in	DMEM	supplemented	with	10	%	heat-inactivated	FBS,	2	mM	L-33	glutamine,	 and	 1	 mM	 sodium	 pyruvate.	 Mouse	 mammary	 carcinoma	 cells	 (TS/A-pc)32	 were	 cultured	 in	 RPMI	 1640	 glutaMAXTM	34	medium	supplemented	with	10	%	heat-inactivated	FBS.	The	cells	were	cultured	at	37	°C	under	a	humidified	atmosphere	containing	5	35	%	CO2.	The	cells	were	detached	by	trypsin	and	counted	under	the	microscope	using	a	Malassez	cell.	The	cells	were	then	centrifuged	36	(5	 min,	 200	 g)	 and	 the	 pellet	 was	 resuspended	 in	 appropriate	 medium	 or	 sterile	 NaCl	 0.9%	 for	 extemporaneous	 subcutaneous	37	implant	to	mice.	38	
Analysis	of	CD44	receptor	expression	of	cells		39	To	measure	expression	of	the	HA-binding	receptor	CD44	in	TS/A-pc	and	HeLa	cells,	TS/A-pc	and	HeLa	cells	were	seeded	into	a	6-40	well	plate	at	a	density	of	5	×	105	cells	per	well	and	incubated	for	24	h	at	37	°C	 in	a	humidified	atmosphere	of	5%	CO2.	Cells	were	41	trypsinated,	counted	and	washed	before	incubation	for	1	h	in	300	µL	of	PBS	containing	10	µL	of	fluorescein	isothiocyanate	(FITC)-42	conjugated	mouse	anti-human	CD44	antibody	(#555478	from	BD	Pharmingen)	at	4	°C.	FITC	mouse	IgG2b	κ	antibody	was	used	as	43	isotype	control	(#	555742	from	BD	Pharmingen).	After	three	washing	with	PBS,	the	cells	were	observed	using	fluorescence-activated	44	cell	 sorting	 (FACS)	Accuri	 6	 (Becton,	Dickinson	 and	Company,	 Pont	de	Claix,	 France).	 Cells	were	 gated	 to	 exclude	 cell	 debris	 and	45	10,000	events	were	recorded	in	the	gate	for	fluorescence	intensity	measurement.		46	
In	vitro	enzyme	degradation	of	nanogels	47	In	the	enzymatic	biodegradation	experiments,	several	suspensions	of	crosslinked	HA-m-poly(DAAM-co-DMA)	nanogels	(1	mg/mL)	48	in	PBS	 (pH	=	7.4)	 containing	hyaluronidase	 at	different	 concentrations	 (20,	 40,	 60	 and	100	U/mL)	were	 incubated	 at	37	 °C.	At	 a	49	
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predetermined	period,	the	light	scattering	intensity,	polydispersity	index	and	mean	diameter	of	the	samples	were	measured	at	37	°C	1	by	DLS.		2	
Cellular	uptake	of	nanogels	and	In	vitro	cytotoxicity	3	 HeLa	and	TSA	cells	were	plated	in	4-wells	Lab-Tek	I	Chamber	slide	(NuncTM,	Thermo	Scientific)	(50,000	cells	in	500	µL	of	culture	4	medium)	and	incubated	overnight	in	DMEM	medium	at	37	°C	and	5%	CO2.	Uptake	experiments	were	performed	by	incubating	cells	5	during	4	h,	8	h,	and	24	h	with	Cy5.5-labeled	crosslinked	nanogels	solution	(100	µg/mL)	at	37	°C	and	5	%	CO2.	For	confocal	imaging,	6	cells	were	fixed	in	4%	paraformaldehyde	for	10	min,	and	microscopy	images	were	recorded	on	a	Zeiss	LMS510	microscope.	Images	7	were	processed	with	ImageJ	software.	Similar	protocol	was	observed	for	FACS	experiment,	with	a	4	and	a	24	h	incubation	with	PBS	8	containing	Cy5.5-labeled	crosslinked	nanogels	solution	(50	µg/mL).	After	three	washing	with	PBS,	the	cells	were	observed	using	LSR	9	II	(Becton,	Dickinson	and	Company,	Pont	de	Claix,	France).	Cells	were	gated	to	exclude	cell	debris	and	10,000	events	were	recorded	10	in	 the	gate	 for	 fluorescence	 intensity	measurement.	 For	 the	 cytotoxicity	 assay,	HeLa	and	TSA	were	 seeded	at	5	 x	105	 cells/mL	 in	11	DMEM	containing	FBS,	in	96-well	microplates	at	37	°C,	5%	CO2	atmosphere.	After	24	h,	the	cells	were	treated	with	the	crosslinked	12	nanogels	and	initial	HA,	at	different	concentrations.	After	72	h	of	incubation,	the	cultures	were	evaluated	by	MTS	assay.	13	
In	vivo	biodistribution	14	The	 in	vivo	 behavior	of	 crosslinked	nanogels	was	 tested	 in	nude	mice	bearing	HeLa	or	TS/A-pc	 subcutaneous	grafts	 in	 their	 right	15	flank	 (n	=	3/condition).	 Female	 NMRI	 nude	 mice	 (6–8	weeks,	 Janvier,	 Le	 Genest-Saint-Isle,	 France)	were	 injected	 subcutaneously	16	with	 1	×	106	 of	 cells	 per	 mouse.	 After	 tumor	 growth	 (10-12	 days	 for	 TS/A-pc	 and	 3	 weeks	 for	 HeLa),	 anesthetized	 mice	17	(isoflurane/oxygen	3.5/4	%	for	induction	and	1.5/2	%	thereafter;	CSP,	Cournon,	France)	were	injected	in	the	tail	vein	with	100	μL	of	18	a	dispersion	of	Cy5.5-labeled	crosslinked	nanogel	(3	g/L	in	PBS).	For	comparison,	Cy5.5-labeled	HA	(3	g/L	in	PBS)	was	also	injected.	19	Fluorescence	images	were	acquired	by	a	back-thinned	CCD	camera	(ORCAII-BT-512G,	Hamamatsu,	Massy,	France)	after	30	min,	1	h,	20	2	h	30,	5	h,	24	h	and	48	h	of	the	injection.	After	the	imaging,	at	24	h	and	48	h,	the	organs	and	the	blood	were	collected	and	imaged.	21	Image	 display	 and	 analysis	 were	 performed	 using	 Wasabi	 software	 (Hamamatsu,	 Massy,	 France).	 Semi-quantitative	 data	 were	22	obtained	by	drawing	regions	of	interest	(ROI)	around	each	organ.	All	procedures	and	experimental	protocols	were	approved	by	the	23	ethical	committee	of	Grenoble	(France)	for	the	use	of	animal	research.	24	
Results	and	discussion	25	
Synthesis	and	characterization	of	core-crosslinked	nanogels	26	To	prepare	core-crosslinked	nanogels,	our	approach	was	to	 functionalize	HA	with	a	thermosensitive	ketone-containing	copolymer	27	prepared	 from	 diacetone	 acrylamide	 and	 N,N-dimethylacrylamide	 as	 illustrated	 in	 Figure	 1.	 DAAM	 is	 not	 only	 interesting	 as	 a	28	crosslinkable	group	but	also	as	a	hydrophobic	co-monomer	of	DMA,	which	allows	to	prepare	copolymers	exhibiting	a	lower	critical	29	solution	 temperature	 (LCST)	below	 the	body	 temperature.26	DAAM	and	DMA	were	 copolymerized	by	RAFT	polymerization	using	30	AIBN	 as	 an	 initiator	 and	 2-(butylthiocarbonothioylthio)propanoic	 acid	 as	 a	 chain	 transfer	 agent	 (CTA).	 The	 molar	 ratio	 of	31	monomers:CTA	was	fixed	at	100:1	with	a	DAAM/DMA	feed	ratio	of	2:1.	The	kinetic	plots	proved	that,	in	these	reaction	conditions,	32	
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Figure	1.	Synthesis	of	poly(DAAM-co-DMA)	and	its	covalent	grafting	on	hyaluronic	acid	by	a	thiol-maleimide	coupling	reaction.	
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PABTC	allowed	a	good	control	over	the	RAFT	copolymerization	of	DAAM	and	DMA,	resulting	in	a	copolymer	with	a	final	DAAM/DMA	1	composition	of	57:33	(Figure	S1).	The	resulting	copolymer	displayed	a	low	dispersity	(Đ)	value	(1.11)	with	a	number	average	molar	2	mass	Mn	 of	 16.45	 kg/mol.	 Its	 structural	 integrity	was	 ascertained	using	 1H-NMR	analysis	 (Figure	 S2).	 The	 copolymer	 exhibited	 a	3	cloud	point	temperature	of	25.5	°C	(Figure	S3).	Subsequently,	poly(DAAM-co-DMA)	of	which	the	RAFT	trithiocarbonate	end-group	4	was	 converted	 to	a	 free	 thiol	by	aminolysis	using	n-butylamine	was	grafted	onto	HA	 (Mw	=	40	kg/mol,	namely	HA40)	 containing	5	maleimide	moieties	(DS	=	0.15,	derived	from	1H	NMR	analysis)	by	formation	of	a	thioether	bond29	(Figure	1).		6	 After	conversion	of	the	remaining	maleimide	units	to	carboxylic	acid	derivatives	by	addition	of	an	excess	of	mercaptopropionic	7	acid,	 the	HA-m-poly(DAAM-co-DMA)	conjugate	was	purified	via	a	batch	 ion	exchange	process,	and	 finally	dialyzed.	The	structural	8	integrity	of	the	HA-m-poly(DAAM-co-DMA)	was	ascertained	by	1H	NMR	analysis.	Indeed,	comparison	of	the	1H	NMR	spectra	of	initial	9	HA	and	HA-m-poly(DAAM-co-DMA)	shows,	for	the	latter	compound,	the	appearance	of	new	signals	in	the	regions	of	3.2-2.1	ppm	and	10	1.7-1.1	 ppm,	 corresponding	 to	 the	 protons	 of	 the	 maleimide-copolymer	 and	 maleimide-mecaptopropionic	 acid	 adducts,	 which	11	confirms	 the	 successful	 grafting	 of	 the	 copolymer	 on	 HA	 (Figure	 2).	 The	 degree	 of	 substitution	 of	 the	 conjugate,	 determined	 by	12	carbazole	assay,30	was	found	to	be	0.10.	13	 	14	
	15	
Figure	2.	1H	NMR	spectrum	(400	MHz,	6	g/L	in	D2O,	25	°C)	of	HA-m-poly(DAAM-co-DMA).	16	 HA-m-poly(DAAM-co-DMA)	is	subjected	to	a	sol-gel	transition	upon	heating	in	phosphate	buffer	saline	(PBS,	pH	7.4)	owing	to	the	17	temperature-responsive	behaviour	of	the	grafted	copolymer.	Nanogels	were	thus	obtained	above	32	°C,	corresponding	to	the	critical	18	aggregation	temperature	(CAT)	of	HA-m-poly(DAAM-co-DMA).	This	was	determined	by	measuring	the	light	scattering	intensity	of	a	19	solution	of	the	HA	derivative	in	PBS	(0.5	g/L)	as	a	function	of	temperature	(Figure	S4).	The	higher	value	of	the	CAT	compared	to	the	20	
Tcp	 of	 the	 copolymer	 poly(DAAM-co-DMA)	 can	 be	 related	 to	 the	 presence	 of	 the	 highly	 hydrophilic	 and	 negatively	 charged	 HA	21	backbone.	Dynamic	light	scattering	measurements	at	40	°C	showed	that	the	nanogels	had	a	hydrodynamic	diameter	around	145	nm	22	with	 a	 low	 polydispersity	 index	 (PDI)	 of	 0.11	 (Table	 1).	 The	 resulting	 nanogels	 were	 subsequently	 rendered	 temperature-23	irreversible	by	hydrazone-bond	crosslinking	the	keto-functional	copolymer	chains	with	a	bishydrazide,	isophtalic	dihydrazide	(IDH),	24	in	aqueous	medium	as	shown	in	Scheme	1.		25	
Table	1.	Average	diameter	and	PDI	of	HA-p-poly(DAAM-co-DMA)	nanogels.	26	
	27	 The	 cryo-TEM	 and	 SEM	 images	 of	 nanogel	 suspensions	 vitrified	 and	 dried	 at	 5	 °C	 revealed	 the	 presence	 of	 nanogels	 at	 low	28	temperature	(Figure	3C	and	3E).	In	accordance	to	the	DLS	data	(Table	1	and	Figure	3B),	the	nanogels	at	40	°C	observed	by	cryo-TEM	29	had	a	diameter	below	200	nm	(Figure	3D).	The	nanogels	at	5	°C	had	a	diameter	around	200	nm	(Figure	3C).	This	is	in	line	with	DLS	30	analysis	which	indicated	an	increase	of	the	average	diameter	of	the	nanogels	from	150	to	247	nm	by	lowering	the	temperature	from	31	
 
 18 °C 40 °C 
Diametera (nm) PDI Diameter (nm)a PDI 
Non-crosslinked 
nanogels 
--b --b 144.6 ± 1.4 
 
0.11 
 
Crosslinked 
nanogels (0.5 equiv. 
IDH) 
247.1 ± 1.1 0.15 
 
150.6 ± 2.4 
 
0.10 
 
a) Z-Average diameter; b)no nanogel formation below the CAT 
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40	 to	18	 °C	 (Table	1).	 The	 larger	 size	 of	 the	nanogels	 at	 18	 and	5	 °C	 can	be	 attributed	 to	 increased	hydration	of	 the	 crosslinked	1	copolymer	chains,	resulting	in	the	nanogel	swelling.	In	the	SEM	images,	the	size	of	the	nanogels	appeared	to	be	much	smaller	due	to	2	shrinkage	during	drying.		3	
	4	
Figure	3.	Size	distribution	of	HA-based	nanogels	crosslinked	with	an	IDH:	ketone	molar	ratio	of	0.5	measured	by	DLS	at	18	°C	(A)	and	40	°C	(B);	morphology	5	observed	at	5	°C	(C,	E)	and	40	°C	(D,	F)	by	cryo-TEM	(C,	D)	and	SEM	(E,	F).	6	 In	the	next	step,	we	varied	the	IDH	to	ketone	molar	ratio	from	0.5	to	1.5	in	the	crosslinking	step	to	ensure	that	all	nanogels	were	7	sufficiently	 crosslinked	 to	 be	 stable	 at	 low	 temperature.	 The	 SEM	 images	 obtained	 from	 crosslinked	nanogel	 suspensions	 at	 5	 °C	8	suggested	a	slightly	lower	amount	of	nanogels	crosslinked	using	an	IDH	to	ketone	molar	ratio	of	0.5	(Figure	4A,	B	and	C).	This	was	9	confirmed	by	static	light	scattering	experiments	performed	on	the	non-crosslinked	and	crosslinked	nanogels	(Figure	4D).	The	non-10	crosslinked	 nanogels	 showed	 a	 continuous	 decrease	 of	 the	 light	 scattering	 intensity	 (LSI)	 from	 40	 to	 15	 °C,	 indicating	 gradual	11	disassembly	of	the	nanogels	due	to	hydration	of	the	thermosensitive	copolymer	chains.	The	LSI	of	the	nanogels	crosslinked	with	0.5	12	molar	 equiv.	 of	 IDH	 slightly	decreased	upon	 cooling,	 suggesting	 a	 small	 extent	 of	 nanogel	 dissociation.	 In	 contrast,	 the	LSI	 of	 the	13	nanogels	 crosslinked	with	1	and	1.5	molar	equiv.	of	 IDH	was	constant	upon	cooling,	demonstrating	efficient	nanogel	 crosslinking	14	under	these	conditions.	15	
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Figure	4.	Influence	the	IDH	to	ketone	molar	ratio	on	the	stability	of	nanogels	at	low	temperature.	SEM	observation	at	5	°C	of	HA-based	nanogels	crosslinked	2	with	IDH	to	ketone	molar	ratios	of	0.5	(A),	1.0	(B)	and	1.5	(C),	and	light	scattering	intensity	of	non-crosslinked	HA-based	nanogels	and	nanogels	crosslinked	3	with	IDH	to	ketone	molar	ratios	of	0.5,	1.0	and	1.5	upon	cooling	from	40	to	15	°C	(D).	4	 These	results	also	indicate	that	the	crosslinking	density	can	be	tuned	by	varying	the	degree	of	dihydrazide	to	diacetone	monomer	5	molar	 ratio.	 Compared	 to	 strategies	 previously	 used	 for	 covalently	 crosslinking	 self-assembled	 nanoparticles	 based	 on	HA,16	 this	6	approach	 based	 on	 keto-hydrazide	 chemistry	 has	 the	 advantage	 of	 controlling	 efficiently	 the	 extent	 of	 crosslinking.	 As	 the	7	acylhydrazone	can	be	hydrolyzed	under	acidic	conditions,	we	evaluated	the	hydrolytic	stability	of	the	cross-linked	nanogels	at	the	8	endosomal	pH	of	5.	We	found	that	at	this	pH,	the	nanogels	remained	stable	for	prolonged	periods	of	time	at	37	°C.	We	attribute	this	9	to	the	hydrophobic	environment	within	the	collapsed	copolymer	domains.	Moreover,	 in	a	previous	study	on	macrogels	 formed	by	10	crosslinking	poly(DAAM-co-DMA)	with	adipic	acid	dihydrazide,	the	networks	were	shown	to	remain	stable	for	several	days	at	pH	6.22	11	A	pH	of	2.5	was	required	 to	observe	degradation	 in	 less	 than	a	day.	Since	HA	can	be	readily	degraded	 to	 lower	molecular	weight	12	components	 by	 hyaluronidase	 (HAase)	 after	 being	 taken	 up	 by	 cancer	 cells,14	we	 also	 investigated	 the	 enzymatic	 degradation	 of	13	crosslinked	nanogels	using	different	concentration	of	HAase	(20,	40,	60	and	100	U/mL)	by	DLS	at	37	°C.	The	light	scattering	intensity	14	of	the	samples	was	found	to	rapidly	drop,	leveling	off	at	1	h	post-addition	of	HAase.	At	this	time,	the	LSI	was	reduced	by	about	75%	15	and	48	%	for	HAase	concentrations	of	20	and	40	U/mL,	respectively	(Figure	S5).	Meanwhile,	the	PDI	and	the	particle	size	increased	16	to	~	0.35	and	~	200	nm,	respectively.	Further	increase	of	HAase	concentration	had	no	significant	effect	on	the	LSI	and	PDI	values	and	17	the	mean	size	did	not	change	(~	180	nm).	These	data	suggest	partial	degradation	of	nanogels	due	to	the	ability	of	HAase	to	hydrolyze	18	the	 outer	HA	 layer	 of	 the	particles.	 The	 evaluation	 of	 the	 biological	 properties	was	performed	using	 crosslinked	nanogels,	which	19	were	stable	upon	long-term	storage,	as	revealed	by	the	perfect	solubilization	of	the	product	in	aqueous	solution	after	freeze-drying.	20	By	contrast,	non-crosslinked	HA-m-poly(DAAM-co-DMA)	was	not	stable	enough;	this	may	be	due	to	side	reactions	involving	ketone	21	functional	 groups	 though	 they	 are	more	 stable	 than	 aldehydes.	 The	 crosslinking	 step	 constitutes	 therefore	 an	 innovative	way	 to	22	stabilize	the	nanogels.	23	
In	vitro	cellular	uptake	evaluation	and	in	vivo	targeting	properties	of	nanogels	based	on	HA-m-poly(DAAM-co-DMA)	24	 The	 intracellular	 uptake	 behaviour	was	 observed	 by	 confocal	microscopy	 in	 two	 cancer	 cell	 lines,	 TS/A-pc	 (mouse	mammary	25	adenocarcinoma)	and	HeLa	(human	cervical	cancer	cells),	after	4	h,	8	h,	and	24	h	incubation	with	the	crosslinked	nanogels	labeled	26	with	 Cy5.5.	 As	 shown	 in	 Figure	 5,	 the	 time	 dependent	 cellular	 uptake	 of	 nanogels	 was	 more	 pronounced	 in	 HeLa	 cells,	27	overexpressing	 the	 CD44	 receptor	 for	 HA	 than	 that	 in	 TS/A-pc	 cells	 which	 do	 not	 express	 CD44	 (see	 experimental	 section	 and	28	supporting	information,	Figure	S6).	The	internalized	nanogels	were	mainly	observed	into	small	vesicles,	or	diffused	in	the	cytoplasm.	29	This	high	uptake	by	HeLa	cells	was	confirmed	by	FACS	experiments,	and	increased	between	4	h	and	24	h,	as	indicated	in	Figure	5.	30	Such	accumulation	may	be	related	to	the	overexpressed	CD44	receptor	in	HeLa	cells33-35,	and	was	safe	for	both	cell	lines	(see	Figure	31	S7).	 Indeed,	 CD44	 binds	 HA	 and	 enables	 its	 internalization	 and	 intracellular	 degradation.14	 In	 this	 regard,	 several	 studies	32	demonstrated	that	the	degree	of	intracellular	uptake	of	HA	nanoparticles	depends	on	the	receptor	density	of	the	cells;	higher	CD44	33	receptor	 density	 correlates	 with	 higher	 HA	 nanoparticle	 uptake.17,	 36-38	 The	 in	 vivo	 biodistribution	 and	 tumor	 accumulation	 of	34	crosslinked	 nanogels	 (with	 0.5	 equiv.	 IDH)	 labeled	 with	 Cy5.5	 were	 assessed	 by	 non-invasive	 full	 body	 fluorescence	 imaging	35	following	their	intravenous	administration	in	HeLa	and	TS/A-pc	tumor-bearing	mice,	and	compared	to	the	biodistribution	of	Cy5.5-36	labeled	 HA.	 TS/A-pc	 tumor	 model	 was	 selected	 in	 addition	 to	 HeLa	 cell	 tumor	 because	 of	 its	 high	 capacity	 to	 accumulate	37	nanoparticles	via	the	EPR	effect39.		38	
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Figure	5.	Confocal	imaging	of	HeLa	(A)	and	TS/A-pc	(C)	cells,	4	h,	8h,	and	24	h	after	incubation	with	Cy5.5-HA-m-poly(DAAM-co-DMA)	crosslinked	nanogels.	3	The	Cy5.5-labeled	crosslinked	nanogels	are	represented	by	red	color,	while	the	cell	nuclei	are	in	blue.	Scale	bar:	10	µm.	(B;	D)	FACS	analysis	were	performed	4	on	the	same	cell	lines	after	4	h	(red	line)	or	24	h	(blue	line)	and	are	compared	to	control	condition	(Black	line).	5	 The	fluorescence	signal	of	the	crosslinked	nanogel	was	recorded	as	a	function	of	time	in	animals,	and	also	in	organs	after	sampling	6	at	24	and	48	h.	Fluorescence	intensity	in	the	tumor	gradually	increased	up	to	24-48	h	for	both	tumor	types	but	to	a	greater	extent	in	7	TS/A-pc	tumor-bearing	mice	(Figure	6A).	Indeed,	TS/A-pc	tumors	strongly	accumulated	the	nanogels	at	24	h	with	an	ex-vivo	tumor-8	to-liver	ratio	reaching	≈	1	and	a	tumor-to-muscle	ratio	reaching	≈	25	(versus	≈	0.2	and	<	3.5,	respectively	for	HeLa	tumors,	see	Figure	9	6B	 and	 C).	 One	 should	 note	 that	 these	 ratios	were	 almost	 stable	 between	 24	 and	 48	 h.	 Tumors	maintained	 strong	 fluorescence	10	intensities	during	two	days	as	evidenced	by	quantitative	analysis	(Figure	6D).	This	indicated	that	nanogels	could	circulate	for	a	long	11	period	of	time	in	the	body	and	continuously	accumulate	at	the	tumor	site.	The	lower	level	of	accumulation	of	the	nanogels	in	HeLa	as	12	compared	to	TS/A-pc	tumors	(Figure	6B	and	6C)	supports	the	idea	that	the	capture	of	nanogels	is	mostly	sensitive	to	an	EPR-driven	13	passive	accumulation	rather	 than	a	CD44-dependent	 targeted	one.	This	also	reflects	 that	passive	accumulation	of	nanoparticles	 is	14	dependent	on	the	tumor	type.39-41		15	 	16	
	17	
Figure	6.	(A)	In	vivo	near-infrared	ﬂuorescence	(NIRF)	images	of	the	time	dependent	biodistribution	of	Cy5.5-labeled	crosslinked	nanogels	in	breast	TS/A-pc	18	and	HeLa	tumor-bearing	mice	(n	=	3/tumor	type).	The	tumor	was	engrafted	subcutaneously	on	the	right	flank	of	the	mouse.	The	fluorescence	was	measured	19	at	 the	 following	 time	 elapse	 after	 administration:	 0	min,	 30	min,	 1	 h,	 2	 h	 30,	 5	 h,	 24	 h,	 and	 48	 h.	 The	 tumor	 locations	 are	 indicated	 by	 the	 arrows.	 (B)	20	Fluorescence	 intensity	 of	 the	 tumor-to-liver	 ratios	 at	 24	 h	 (blue)	 and	 48	 h	 (orange)	 post-injection	 and,	 (C)	 tumor-to-muscle	 ratios	 from	 excised	 organs	21	sampled	at	24	h	(blue)	and	48	h	(orange)	post-injection.	The	results	are	expressed	as	the	mean	±	SD	(n=3).	(D)	Quantiﬁcation	of	the	ex	vivo	biodistribution	of	22	Cy5.5-labeled	crosslinked	nanogels	in	mice,	24	h	and	48	h	after	administration	(n	=	6/organ).	ROIs	were	defined	on	the	extracted	organs	to	semi-quantify	the	23	amount	of	photons	detected	per	pixel.	The	results	in	each	organ	are	expressed	as	the	mean	of	relative	light	unit	per	pixel	per	ms	±	SD	(n=6).	24	
B C 
D 
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Interestingly,	similar	results	for	native	HA	accumulation	were	observed	as	described	in	Figure	S8.	Only	the	tumor-to-muscle	ratios	1	were	 different	 from	 the	 nanogels,	 reaching	 7.18-12.42	 for	 HeLa	 tumors,	 and	 15.59-8.73	 for	 TS/A-pc	 tumors,	 at	 24	 and	 48	 h,	2	respectively	(Figure	S8B	and	S8C).	This	highlights	the	fact	that	accumulation	of	nanogels	in	the	tumor	is	governed	by	both	the	nature	3	of	their	hydrophilic	shell	and	their	nanoparticle	form.	The	nanogel	fluorescence	was	also	detected	in	other	organs	to	various	extents,	4	with	 liver	 and	 spleen	 characterized	 by	 the	 highest	 nanogel	 accumulations	 at	 both	 24	 and	 48	 h	 post	 injection	 (Figure	 6D).	 This	5	accumulation	may	be	due	to	cellular	uptake	of	the	nanogels	by	phagocytic	cells	of	the	reticuloendothelial	system.	It	is	known	that	the	6	liver	 is	 the	 major	 organ	 that	 uptakes	 and	 accumulates	 any	 types	 of	 nano/micro	 particles	 with	 high	 hydrodynamic	 radius.42	7	Accumulation	in	liver	and	spleen	may	also	be	related	to	nanogel	clearance	from	circulation	mediated	by	the	hyaluronan	receptor	for	8	endocytosis	 (HARE),	which	 is	 found	 primarily	 in	 the	 sinusoidal	 endothelial	 cells	 of	 the	 liver	 and	 spleen.14,	43,	44	 Regarding	HA,	 its	9	fluorescence	signal	was	detected	with	high	intensity	in	liver,	spleen	as	well	as	in	intestine,	skin	and	ovary	(Figure	S8D).	Collectively,	10	these	results	 suggest	 that	crosslinked	nanogels	exhibit	high	 tumor	uptake,	probably	 in	correlation	with	 the	EPR	properties	of	 the	11	tumor,	and	improved	biodistribution	even	after	48	h	post-injection.	12	
Conclusions	13	In	this	study,	novel	biocompatible	nanogels	were	fabricated	from	hyaluronic	acid	modified	with	a	ketone-functional	copolymer.	The	14	nanogels	 were	 prepared	 by	 a	 simple	 method	 based	 on	 the	 temperature-triggered	 assembly	 of	 the	 HA	 conjugate	 followed	 by	15	crosslinking	 the	 hydrophobic	 nanodomains	 of	 the	 copolymer	 chains	 by	 hydrazone	 formation.	 These	 crosslinks	 throughout	 the	16	hydrophobic	domains	in	the	core	of	the	nanogels	do	not	affect	the	shell-forming	polysaccharide	structure.	In	addition,	their	density	17	can	 be	 tuned	 by	 varying	 the	 dihydrazide	 crosslinker	 to	 ketone	 group	 molar	 ratio.	 In	 vitro	 biological	 studies	 revealed	 that	 the	18	nanogels	were	 internalized	 into	 different	 cell	 types,	with	 a	main	 vesicle	 accumulation.	 Finally,	 in	 vivo	studies	 demonstrated	 that	19	following	intravenous	administration	in	tumor-bearing	mice,	the	crosslinked	nanogels	were	able	to	circulate	in	the	bloodstream	for	a	20	long	 period	 of	 time	 and	 accumulated	 in	 the	 tumor	 tissues,	 probably	 in	 correlation	with	 the	 EPR	 properties	 of	 the	 tumor.	 These	21	results	suggest	that	these	nanogels	hold	great	potential	in	anti-cancer	therapy,	as	they	efficiently	reach	the	vascularized	tumor.	They	22	represent	a	versatile	platform	to	introduce	additional	functionalities	and/or	tune	the	properties	of	the	hydrophilic	shell	in	order	to	23	more	optimally	exploit	 the	biocompatibility	and	 the	beneficial	distribution	of	 these	novel	nanocarriers	 that	might	be	used	 for	 the	24	delivery	of	chemotherapeutics.	25	
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